AG0069OY

70359-46-5 | (2R,3R)-2,3-dihydroxybutanedioic acid; 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine

Chemical structure of (2R,3R)-2,3-dihydroxybutanedioic acid; 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, CAS 70359-46-5
AG0069OY
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 70359-46-5
Catalog Number AG0069OY(AGN-PC-0TY20L)
Chemical Name (2R,3R)-2,3-dihydroxybutanedioic acid; 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
IUPAC Name 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
InChI InChI=1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
InChI Key QZHBYNSSDLTCRG-LREBCSMRSA-N
MDL Number MFCD07773072
Molecular Formula C15H16BrN5O6
Molecular Weight 442.2214
SMILES BrC1=C2N=CC=NC2=CC=C1NC3=NCCN3.O=C(O)[C@H](O)[C@@H](O)C(O)=O
UNII 4S9CL2DY2H
Synonyms
5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate, 5-bromo-6-(imidazolidinylideneamino)quinoxaline, 5-bromo-6-(imidazolin-2-ylamino)quinoxaline, AGN 190342, AGN-190342, AGN190342, Alphagan, Alphagan P, brimonidine, brimonidine Purite, brimonidine tartrate, brimonidine tartrate (1:1), brimonidine tartrate (1:1), (S-(R*,R*))-isomer, brimonidine tartrate, (R-(R*,R*))-isomer, bromoxidine, mirvaso, Ratio Brimonidine, ratio-Brimonidine, Sanrosa, UK 14,304, UK 14,304 18, UK 14,304-18, UK 14,30418, UK 14,308, UK 14304, UK 14308, UK-14,304-18, UK-14,308, UK-14304, UK14,30418, UK14,308, UK14304, BRIMONIDINE TARTRATE, 70359-46-5, Brimonidine tartarate, Brominide tartrate, Alphagan, Brimonidine D-tartrate, UNII-4S9CL2DY2H, Brimonidinne tartrate, C11H10BrN5.C4H6O6, Brimonidine L-Tartrate, Brimonidine (tartrate), Brimonidine D-tartarate, 4S9CL2DY2H, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate, UK-14304-18, Qoliana, (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1h-imidazol-2-yl)-amine L-tartrate, brimonidine Purite, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine; (2R,3R)-2,3-dihydroxybutanedioic acid, 59803-99-5, Brimonidine tartrate [USAN], AGN-190342-LF, Alphagan-P, AGN 190342LF, Brimonidine tartrate [USAN:JAN], N-(5-bromoquinoxalin-6-yl)imidazolidin-2-imine;(2R,3R)-2,3-dihydroxybutanedioic acid, Alphagan (TN), brimonidine-tartrate, 5-bromo-N-, UK14304 tartrate, AC1L1GYC, AGN190342 tartrate, AC1Q59OR, UK 14,304 (tartrate), SCHEMBL265607, HY-B0659A, Brimonidine tartrate (JAN/USAN), HMS3715P18, AGN 190342-LF, ACT08633, EBD23481, KS-00000K6V, MFCD07773072, AKOS016845265, CCG-221278, CS-4496, Brimonidine tartrateUK 14,304 tartrate, AN-12800, AS-18083, AB0021226, LS-177484, ST24046243, W0014, A19740, D02076, 359B465, brimonidine tartrate (1:1), (S-(R*,R*))-isomer, (4,5-Bihydro-1H-imidazol-2-yl)quinoxalin-6-amine L-tartrate, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl) quinoxalin-6-amine tartrate, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine L-Tartrate, 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1), 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1), brimonidine, Alphagan P, mirvaso, Lumify, UK 14,304 tartrate, D00ARM, CID54405, CS-O-03921, C11-H10-Br-N5.C4-H6-O6, 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline, A13433, Brimonidine tartrate, 98.5% - 100MG 100mg, 79570-19-7, 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate (1:1), 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate, 59803-98-4, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine(2R,3R)-2,3-dihydroxysuccinate, 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1),

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited